Clinical trials
Terminated Adenoma, Islet Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2009 | 1 |
| 2011 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 2 |
| Novartis Pharmaceuticals | 1 |
| University of California, San Francisco | 1 |
| Vanderbilt-Ingram Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenoma, Islet Cell | 5 |
| Carcinoma, Islet Cell | 4 |
| Gastrinoma | 4 |
| Glucagonoma | 4 |
| Insulinoma | 4 |
| Somatostatinoma | 4 |
| Neoplasms | 3 |
| Vipoma | 3 |
| Carcinoma, Medullary | 2 |
| Head and Neck Neoplasms | 2 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.